1. Home
  2. COEP vs IPM Comparison

COEP vs IPM Comparison

Compare COEP & IPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • IPM
  • Stock Information
  • Founded
  • COEP 2017
  • IPM 2005
  • Country
  • COEP United States
  • IPM United States
  • Employees
  • COEP N/A
  • IPM N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • IPM
  • Sector
  • COEP Health Care
  • IPM
  • Exchange
  • COEP Nasdaq
  • IPM NYSE
  • Market Cap
  • COEP 27.4M
  • IPM 27.9M
  • IPO Year
  • COEP N/A
  • IPM N/A
  • Fundamental
  • Price
  • COEP $11.15
  • IPM $2.03
  • Analyst Decision
  • COEP
  • IPM Strong Buy
  • Analyst Count
  • COEP 0
  • IPM 1
  • Target Price
  • COEP N/A
  • IPM $6.00
  • AVG Volume (30 Days)
  • COEP 56.9K
  • IPM 32.0K
  • Earning Date
  • COEP 08-15-2025
  • IPM 08-13-2025
  • Dividend Yield
  • COEP N/A
  • IPM N/A
  • EPS Growth
  • COEP N/A
  • IPM N/A
  • EPS
  • COEP N/A
  • IPM N/A
  • Revenue
  • COEP $62,874.00
  • IPM $6,344,746.00
  • Revenue This Year
  • COEP N/A
  • IPM $1,957.49
  • Revenue Next Year
  • COEP N/A
  • IPM $17.96
  • P/E Ratio
  • COEP N/A
  • IPM N/A
  • Revenue Growth
  • COEP N/A
  • IPM 14.16
  • 52 Week Low
  • COEP $2.31
  • IPM $1.52
  • 52 Week High
  • COEP $13.70
  • IPM $5.50
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.53
  • IPM N/A
  • Support Level
  • COEP $11.30
  • IPM N/A
  • Resistance Level
  • COEP $12.71
  • IPM N/A
  • Average True Range (ATR)
  • COEP 0.89
  • IPM 0.00
  • MACD
  • COEP 0.18
  • IPM 0.00
  • Stochastic Oscillator
  • COEP 54.39
  • IPM 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About IPM INTELLIGENT PROTECTION MANAGEMENT

Intelligent Protection Management Corp is a communications software innovator that powers multimedia social applications.

Share on Social Networks: